# A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199

> **NCT03880487** · PHASE1 · TERMINATED · sponsor: **Kalyra Pharmaceuticals, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** KP-1199
- **DRUG:** Placebo oral capsule
- **DRUG:** Oxycodone oral capsule

## Key facts

- **NCT ID:** NCT03880487
- **Lead sponsor:** Kalyra Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-12
- **Primary completion:** 2020-04-21
- **Final completion:** 2020-04-21
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** The Study was terminated early by sponsor
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03880487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03880487, "A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03880487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*